DE69026387D1 - Reduktion der nichtzielspezifischen retention von immunokonjugaten und ihren metaboliten - Google Patents

Reduktion der nichtzielspezifischen retention von immunokonjugaten und ihren metaboliten

Info

Publication number
DE69026387D1
DE69026387D1 DE69026387T DE69026387T DE69026387D1 DE 69026387 D1 DE69026387 D1 DE 69026387D1 DE 69026387 T DE69026387 T DE 69026387T DE 69026387 T DE69026387 T DE 69026387T DE 69026387 D1 DE69026387 D1 DE 69026387D1
Authority
DE
Germany
Prior art keywords
immunoconjugates
metabolites
target
reduction
retention
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69026387T
Other languages
English (en)
Other versions
DE69026387T2 (de
Inventor
Mary Ann Gray
Don Axworthy
David Wilkening
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Poniard Pharmaceuticals Inc
Original Assignee
Poniard Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Poniard Pharmaceuticals Inc filed Critical Poniard Pharmaceuticals Inc
Publication of DE69026387D1 publication Critical patent/DE69026387D1/de
Application granted granted Critical
Publication of DE69026387T2 publication Critical patent/DE69026387T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1093—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/44—Antibodies bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Optics & Photonics (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69026387T 1989-09-29 1990-09-24 Reduktion der nichtzielspezifischen retention von immunokonjugaten und ihren metaboliten Expired - Fee Related DE69026387T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41505589A 1989-09-29 1989-09-29
PCT/US1990/005416 WO1991004755A1 (en) 1989-09-29 1990-09-24 Methods for reducing non-target retention of immunoconjugates and metabolites thereof

Publications (2)

Publication Number Publication Date
DE69026387D1 true DE69026387D1 (de) 1996-05-09
DE69026387T2 DE69026387T2 (de) 1996-11-28

Family

ID=23644186

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69026387T Expired - Fee Related DE69026387T2 (de) 1989-09-29 1990-09-24 Reduktion der nichtzielspezifischen retention von immunokonjugaten und ihren metaboliten

Country Status (7)

Country Link
US (2) US5380513A (de)
EP (1) EP0494247B1 (de)
JP (1) JPH05500953A (de)
AT (1) ATE136224T1 (de)
CA (1) CA2066031C (de)
DE (1) DE69026387T2 (de)
WO (1) WO1991004755A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991004755A1 (en) * 1989-09-29 1991-04-18 Neorx Corporation Methods for reducing non-target retention of immunoconjugates and metabolites thereof
GB9417873D0 (en) 1994-09-06 1994-10-26 Sandoz Ltd Organic compounds
US5843894A (en) * 1995-03-21 1998-12-01 Center For Molecular Medicine And Immunology Methods for reduced renal uptake of antibody fragments
WO2001005383A2 (en) * 1999-07-16 2001-01-25 Mallinckrodt, Inc. Inhibition of renal uptake of radiomolecules with a combination of lysine and arginine
ITMI20010347A1 (it) * 2001-02-21 2002-08-21 Grisotech S A Complessi di immunoglobuline e polisaccaridi per assorbimento orale etrans-mucosale
EP1419786A1 (de) * 2002-11-13 2004-05-19 Bracco Imaging S.p.A. Verfahren zur quantitativen und selektiven Funktionalisierung von Immunoglobulin-Fab-Fragmenten, deren Konjugate und deren Zusammensetzungen
US20070184501A1 (en) * 2006-02-07 2007-08-09 Beckman Coulter, Inc. Blocker reagent for reduction of heterophile interferences

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4916213A (en) * 1983-02-22 1990-04-10 Xoma Corporation Ribosomal inhibiting protein-immunoglobulin conjugates with specificity for tumor cell surface antigens, and mixtures thereof
US4624846A (en) * 1983-07-29 1986-11-25 Immunomedics, Inc. Method for enhancing target specificity of antibody localization and clearance of non-target diagnostic and therapeutic principles
EP0268707A3 (de) * 1985-11-05 1989-03-08 The General Hospital Corporation Negativ geladene spezifische Affinitätsreagenzien
US4731244A (en) * 1985-11-13 1988-03-15 Ortho Pharmaceutical Corporation Monoclonal antibody therapy
AU616161B2 (en) * 1986-10-09 1991-10-24 Neorx Corporation Methods for improved targeting of antibody, antibody fragments, hormones and other targeting agents, and conjugates thereof
US5034223A (en) * 1986-10-09 1991-07-23 Neorx Corporation Methods for improved targeting of antibody, antibody fragments, hormones and other targeting agents, and conjugates thereof
US4946675A (en) * 1987-05-27 1990-08-07 Xoma Corporation Hepatic blocking agents
US4859449A (en) * 1987-09-14 1989-08-22 Center For Molecular Medicine And Immunology Modified antibodies for enhanced hepatocyte clearance
US5322678A (en) * 1988-02-17 1994-06-21 Neorx Corporation Alteration of pharmacokinetics of proteins by charge modification
US5171563A (en) * 1988-09-30 1992-12-15 Neorx Corporation Cleavable linkers for the reduction of non-target organ retention of immunoconjugates
WO1991004755A1 (en) * 1989-09-29 1991-04-18 Neorx Corporation Methods for reducing non-target retention of immunoconjugates and metabolites thereof

Also Published As

Publication number Publication date
DE69026387T2 (de) 1996-11-28
US5380513A (en) 1995-01-10
EP0494247A1 (de) 1992-07-15
CA2066031C (en) 2001-02-27
US5648059A (en) 1997-07-15
EP0494247B1 (de) 1996-04-03
ATE136224T1 (de) 1996-04-15
WO1991004755A1 (en) 1991-04-18
CA2066031A1 (en) 1991-03-30
JPH05500953A (ja) 1993-02-25
EP0494247A4 (de) 1994-03-30

Similar Documents

Publication Publication Date Title
ATE46080T1 (de) Pharmazeutische komposition.
ATE120457T1 (de) Macrocyclische bifunktionelle chelatbildner, komplexe davon und ihre konjugierten antikörper.
FR2540726B1 (fr) Compositions pharmaceutiques anti-inflammatoires pour l'usage topique, leur preparation et leurs utilisations
BE890024A (fr) Derives tricycliques de l'imidazole, leur preparation et leurs utilisations therapeutiques
SE8202172L (sv) Topiska farmaceutiska kompositioner
ES2102196T3 (es) Periferializacion de celulas pluripotenciales hematopoyeticas.
BE889930A (fr) Derives de l'indole, leur preparation et leurs utilisations therapeutiques
NO166267C (no) Konjugat av et maalsoekende biologisk aktivt molekyl og en forbindelse inneholdende spormerkende metall, samt diagnostisk preparat inneholdende konjugatet.
MY107158A (en) 3-arylcarbonyl; -1h-indoles useful as therapeutic agents.
DE59709437D1 (de) Neue phenanthridine
BE889929A (fr) Derives de l'indole, leur preparation et leurs utilisations therapeutiques
ATE136224T1 (de) Reduktion der nichtzielspezifischen retention von immunokonjugaten und ihren metaboliten
EP0174279A3 (de) Cyclosporin-Therapie
EA199800717A1 (ru) Способ лечения заболеваний млекопитающих и цвиттерионная композиция
IT1169873B (it) Composizione farmaceutica ad attivita' sistemica anticolinesterasica, agonista-colinergica ed antimuscarinica
DE69117303D1 (de) Zusammensetzung mit psyllium
AU4140585A (en) 1,4-dihydropyridine-3-carboxylates and salts thereof
DE3687838D1 (de) Deodorant-bettmaterial.
FR2434804A1 (fr) Derives de la n-phenyl-indoline, leur preparation et leur application comme medicaments
BE883943A (fr) Derives de l'enkaphaline, leur preparation et leurs utilisations therapeutiques, notamment comme analgesiques
FI961339A0 (fi) Triaryylieteenijohdannaiset käytettäväksi hoidossa
FR2359838A1 (fr) Guanidines, leur preparation et leur application en therapeutique
ES455721A1 (es) Procedimiento para la preparacion de una nueva sal de pipe- raziniluracilo.
JPS5592325A (en) Antitumor agent and its preparation
FR2335721A1 (fr) Cheville, notmment pour l'ameublement

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee